The Ensign Group Reports Record Net Income, Adjusted Earnings of $0.62 Per Share

Conference Call and Webcast Scheduled for November 8, 2012 at 10:00 am PT


MISSION VIEJO, Calif., Nov. 7, 2012 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (Nasdaq:ENSG), the parent company of the Ensign™ group of skilled nursing, rehabilitative care services, assisted and independent living, home health, hospice care and urgent care companies, today reported operating results for the third quarter of 2012.

Financial highlights for the Third Quarter include:

  • Net income climbed 14.6% to a record $13.3 million;
  • Same-store skilled nursing occupancy grew by 40 basis points over the prior year quarter to 82.1%;
  • Same-store skilled mix days held steady at 28.7% despite reported soft hospital occupancy in many markets, while consolidated skilled days grew by 34 basis points to 25.2% of patient days;
  • Consolidated EBITDAR was a record $34.4 million, an increase of 3.0% over the prior year quarter, and the fourth consecutive sequential increase since the October 1, 2011 implementation of an 11.1% Medicare cut and changes to therapy regulations which increased therapy costs; and
  • Consolidated revenues were a record $207.2 million, up 5.5%.

Operating Results

Ensign matched its adjusted earnings per share for the same quarter of 2011, despite the effects of last October's unprecedented 11.1% reduction in Medicare rates to skilled nursing facilities and a simultaneous change in therapy regulations that increased the cost of delivering physical and other types of therapy to skilled nursing patients.

"We have now successfully navigated a full four quarters under the difficult circumstances posed by last years' cuts, and have posted improved operating results each quarter," said Christopher Christensen, Ensign's President and Chief Executive Officer. He observed that, even though same-store revenues are tracking behind the prior year as a result of the cuts, the 14.6% earnings increase illustrates that Ensign's unique operating model has been able to adjust effectively on the expense side to the new reimbursement realities in skilled nursing care.

Mr. Christensen also highlighted the company's diversification into home health and hospice care, and into subacute care, as further evidence of the organization's agility and ability to quickly adjust in the face of operating headwinds. "As always, it is our empowered and motivated local leaders and their teams that have rallied to make up lost revenues, craft their own unique and innovative ways to get the job done, and again set Ensign apart from the crowd," he said.

Mr. Christensen noted that the last four quarters "have been the perfect storm" for the skilled nursing industry, adding, "And we are grateful that – while we have increased revenue, earnings and occupancy more slowly than last year – we have nevertheless increased, and done so through a very difficult time."

In other results, Chief Financial Officer Suzanne Snapper reported that EBITDA rose nearly $1.0 million to $31.1 million, notwithstanding the October 2011 Medicare cuts and therapy changes. She noted that Ensign, as a growing, dynamic company, had benefitted from the contributions of recently-acquired and transitioning facilities, which posted revenue gains of 80% and 5.7% respectively, more than offsetting the 3.3% decline in same-store revenue resulting from the 2011 cuts.

She also reported that, while much of the industry appears to have suffered a decline in occupancy during the quarter, Ensign's same-store skilled nursing occupancy was actually up by 40 basis points to 82.1%, and same-store occupancy was up 35 basis points to 82.2%. "We believe that as the quality of our service offerings, our superior clinical outcomes and our connections to our individual markets continue to strengthen, we will increasingly draw market share across the portfolio," she added, noting that the largest increases are expected "at the higher end of the acuity spectrum."

Fully diluted GAAP earnings per share were $0.60 for the quarter, an 11.1% increase compared to $0.54 in the third quarter of 2011. Adjusted non-GAAP earnings for the quarter were $0.62 per fully diluted share, compared to $0.62 in the third quarter of 2011. A reconciliation of key GAAP and non-GAAP financial metrics appears in the financial data included with this release. More complete information is contained in the Company's 10-Q, which was filed with the SEC today and can be viewed on the Company's website at http://www.ensigngroup.net.

2012 Guidance Confirmed

Management confirmed its annual guidance, which was increased following the second quarter, projecting adjusted net income of $2.48 to $2.56 per diluted share on revenues of $830 million to $846 million. The guidance is based on diluted weighted average common shares outstanding of 22.1 million and assumes, among other things, no additional acquisitions or dispositions beyond those made to date, the effects of the announced Medicare market basket update, anticipated increases in overall net Medicaid reimbursement rates, a normalized tax rate of approximately 39%, and that tax rates do not materially increase. It also excludes expenses related to normalized rent from one operating lease for a not-yet opened facility and the costs associated with the settlement of the California class action, as well as expenses related to the DOJ investigation which can vary widely from quarter to quarter depending on the DOJ's activities and the required response by the Company.

Quarter Highlights

Dividend Declared

During the quarter, the company's Board of Directors declared a quarterly cash dividend of $0.06 per share of Ensign common stock. Ensign has been a dividend-paying company since 2002, and has increased its dividend every year.

Acquisition Growth

During the quarter, the company announced the acquisition of one skilled nursing and assisted living campus and one skilled nursing facility, both in the same transaction. In addition, the company exercised fixed-formula purchase options on three skilled nursing facilities it has operated for many years. The facilities were purchased with cash, and include:

  • In Idaho, Discovery Care Center, a 45-bed skilled nursing and 24-unit assisted living campus in Salmon.
  • Also in Idaho, Owyhee Health & Rehabilitation Center, a 49-bed skilled nursing facility located in Homedale, a suburb of the growing Boise market.
  • In Southern California, Ensign exercised a purchase option to acquire the underlying real estate of Palomar Vista Healthcare Center, a 74-bed skilled nursing facility located in Escondido. An Ensign subsidiary has operated Palomar Vista since 2003 under a lease from the family that founded the facility.
  • Also in Southern California, Ensign exercised purchase options to acquire the underlying real estate of Atlantic Memorial Healthcare Center, a 104-bed skilled nursing facility, and Shoreline Healthcare Center, a 75-bed skilled nursing facility, both located in the City of Long Beach. Separate Ensign subsidiaries have operated the two facilities since 2002 under leases from the family that built and originally operated the two facilities.

The acquisitions brought Ensign's growing portfolio to 107 facilities, 85 of which are Ensign-owned, with Ensign affiliates holding purchase options on two of Ensign's 22 leased facilities, as well as four hospice companies and six home health businesses, spread over 11 states. Management reaffirmed that Ensign is actively seeking additional opportunities to acquire both well-performing and struggling long-term care, home health and hospice operations across the United States.

Conference Call

A live webcast will be held on Thursday, November 8, 2012 at 10:00 a.m. Pacific Time (1:00 p.m. Eastern Time) to discuss Ensign's third quarter 2012 financial results. To listen to the webcast, or to view any financial or statistical information required by SEC Regulation G, please visit the Investors section of the Ensign website at http://investor.ensigngroup.net. The webcast will be recorded, and will be available for replay via the website until 5:00 p.m. Pacific Time on Friday, November 23, 2012.

About Ensign

The Ensign Group, Inc.'s independent operating subsidiaries provide a broad spectrum of skilled nursing and assisted living services, physical, occupational and speech therapies, home health and hospice services, and other rehabilitative and healthcare services for both long-term residents and short-stay rehabilitation patients at 107 facilities, four hospice companies and six home health businesses in California, Arizona, Texas, Washington, Utah, Idaho, Colorado, Nevada, Iowa, Nebraska and Oregon. Each of these facilities and businesses is operated by a separate, independent operating subsidiary that has its own management, employees and assets. References herein to the consolidated "company" and "its" assets and activities, as well as the use of the terms "we," "us," "its" and similar verbiage, are not meant to imply that The Ensign Group, Inc. has direct operating assets, employees or revenue, or that any of the facilities, the home health and hospice businesses, the urgent care joint venture, the Service Center or the captive insurance subsidiary are operated by the same entity. More information about Ensign is available at http://www.ensigngroup.net.

The Ensign Group, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=13849

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995:

This press release contains, and the related conference call and webcast will include, forward-looking statements that are based on management's current expectations, assumptions and beliefs about its business, financial performance, operating results, the industry in which it operates and other future events. Forward-looking statements can often be identified by words such as "anticipates," "expects," "intends," "plans," "predicts," "believes," "seeks," "estimates," "may," "will," "should," "would," "could," "potential," "continue," "ongoing," similar expressions, and variations or negatives of these words. These forward-looking statements include, but are not limited to, statements regarding growth prospects, future operating and financial performance. They are not guarantees of future results and are subject to risks, uncertainties and assumptions that could cause actual results to materially and adversely differ from those expressed in any forward-looking statement.

These risks and uncertainties relate to the company's business, its industry and its common stock and include: reduced prices and reimbursement rates for its services; its ability to acquire, develop, manage or improve facilities, its ability to manage its increasing borrowing costs as it incurs additional indebtedness to fund the acquisition and development of facilities; its ability to access capital on a cost-effective basis to continue to successfully implement its growth strategy; its operating margins and profitability could suffer if it is unable to grow and manage effectively its increasing number of facilities; competition from other companies in the acquisition, development and operation of facilities; and the application of existing or proposed government regulations, or the adoption of new laws and regulations, that could limit its business operations, require it to incur significant expenditures or limit its ability to relocate its facilities if necessary. Readers should not place undue reliance on any forward-looking statements and are encouraged to review the company's periodic filings with the Securities and Exchange Commission, including its Form 10-Q, which was filed today, for a more complete discussion of the risks and other factors that could affect Ensign's business, prospects and any forward-looking statements. Except as required by the federal securities laws, Ensign does not undertake any obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, changing circumstances or any other reason after the date of this press release.

                   
THE ENSIGN GROUP, INC.
GAAP and ADJUSTED CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(In thousands, except per share data)
 
                   
  Three Months Ended
September 30, 2012
Nine Months Ended
September 30, 2012
  As Reported Non-GAAP Adj.   As Adjusted As Reported   Non-GAAP Adj.   As Adjusted
Revenue  $ 207,150      $ 207,150  $ 613,618        $ 613,618
Expense:                   
Cost of services (exclusive of facility rent, general and administrative and depreciation and amortization expense shown separately below)  164,877 (307) (1)(2)  164,570  488,305    (3,265) (1)(2)(3)  485,040
Facility rent—cost of services  3,374 (153) (4)  3,221  10,063    (445) (4)  9,618
General and administrative expense  8,099 (594) (5)  7,505  23,933    (1,442) (5)  22,491
Depreciation and amortization  7,179 (127) (6)  7,052  21,145    (433) (6)  20,712
Total expenses  183,529 (1,181)    182,348  543,446    (5,585)    537,861
Income from operations  23,621 1,181    24,802  70,172    5,585    75,757
Other income (expense):                   
Interest expense  (3,092)      (3,092)  (9,131)        (9,131)
Interest income  69      69  172        172
Other expense, net  (3,023)      (3,023)  (8,959)        (8,959)
Income before provision for income taxes  20,598 1,181    21,779  61,213    5,585    66,798
Tax Effect on Non-GAAP Adjustments   461 (7)        2,178 (7)  
Tax True-up for Effective Tax Rate   471 (8)        803 (8)  
Provision for income taxes  7,562 932    8,494  23,070    2,981    26,051
Net income  $ 13,036 249    $ 13,285  $ 38,143    2,604    $ 40,747
Less: net loss attributable to noncontrolling interests  (258)      (258)  (511)        (511)
Net income attributable to The Ensign Group, Inc.  $ 13,294 249    $ 13,543  $ 38,654    2,604    $ 41,258
Net income per share:                   
Basic  $ 0.62      $ 0.63  $ 1.81        $ 1.93
Diluted  $ 0.60      $ 0.62  $ 1.77        $ 1.88
Weighted average common shares outstanding:                   
Basic  21,488      21,488  21,369        21,369
Diluted  22,010      22,010  21,899        21,899
                   
 
(1) Represents acquisition-related costs of $110 and $230 for the three and nine months ended September 30, 2012, respectively.
(2) Represents costs of $197 and $439 for the three and nine months ended September 30, 2012, respectively, incurred to recognize income tax credits which contributed to decrease in effective tax rate.
(3) Represents the settlement of a class action lawsuit regarding minimum staffing requirements in the state of California of $2,596 during the three months ended June 30, 2012.
(4) Represents straight-line rent amortization for a facility which the Company has begun construction activities, but has not commenced operations of a skilled nursing facility as of September 30, 2012.
(5) Represents legal costs incurred in connection with the ongoing investigation into the billing and reimbursement processes of some of our subsidiaries being conducted by the Department of Justice (DOJ).
(6) Represents amortization costs related to patient base intangible assets acquired. Patient base intangible assets are amortized over a period of four to eight months, depending on the classification of the patients and the level of occupancy in a new acquisition on the acquisition date.
(7) Represents the tax impact of non-GAAP adjustments noted in (1) – (6) at a normalized rate of 39.0%.
(8) In FY 2011 and 2010, the Company's effective tax rate was 38.3% and 39.3%, respectively. Therefore, this represents an adjustment to the provision for income taxes to normalize our current quarter effective rate to 39.0%.
                 
THE ENSIGN GROUP, INC.
GAAP and ADJUSTED CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(In thousands, except per share data)
 
  Three Months Ended
September 30, 2011
Nine Months Ended
September 30, 2011
  As Reported Non-GAAP Adj.   As Adjusted As Reported Non-GAAP Adj.   As Adjusted
Revenue  $ 196,346      $ 196,346  $ 565,615      $ 565,615
Expense:                 
Cost of services (exclusive of facility rent, general and administrative and depreciation and amortization expense shown separately below)  155,725 (158) (1)  155,567  444,517  (362) (1)  444,155
Facility rent—cost of services  3,331      3,331  10,380      10,380
General and administrative expense  7,195      7,195  22,188      22,188
Depreciation and amortization  6,179 (249) (2)  5,930  16,784  (808) (2)  15,976
Total expenses  172,430 (407)    172,023  493,869  (1,170)    492,699
Income from operations  23,916 407    24,323  71,746  1,170    72,916
Other income (expense):                 
Interest expense  (5,323) 2,542    (2,781)  (10,789)  2,542 (3)  (8,247)
Interest income  68      68  198      198
Other expense, net  (5,255) 2,542    (2,713)  (10,591)  2,542    (8,049)
Income before provision for income taxes  18,661 2,949    21,610  61,155  3,712    64,867
Provision for income taxes  7,063 1,116 (4)  8,179  23,835  1,447    25,282
Net income  $ 11,598 1,833    $ 13,431  $ 37,320  2,265    $ 39,585
Net income per share:                 
Basic  $ 0.55      $ 0.64  $ 1.78      $ 1.89
Diluted  $ 0.54      $ 0.62  $ 1.73      $ 1.84
Weighted average common shares outstanding:                 
Basic  20,995      20,995  20,920      20,920
Diluted  21,570      21,570  21,571      21,571
 
(1) Represents acquisition-related costs expenses.
(2) Represents amortization costs related to patient base intangible assets acquired. Patient base intangible assets are amortized over a period of four to eight months, depending on the classification of the patients and the level of occupancy in a new acquisition on the acquisition date.
(3) Represents the loss on extinguishment and amortization of remaining deferred financing costs in connection with the Senior Credit Facility entered into by the Company on July 15, 2011.
(4) Represents the tax impact of acquisition costs, patient base and loss on extinguishment of debt non-GAAP adjustments represented in entries (1) - (3).
         
THE ENSIGN GROUP, INC.
RECONCILIATION OF NET INCOME TO EBITDA AND EBITDAR
(in thousands)
The table below reconciles net income to EBITDA and EBITDAR for the periods presented:
         
  Three Months Ended
September 30,
Nine Months Ended
Septebmer 30,
  2012 2011 2012 2011
Consolidated Statements of Income Data:        
Net income  $ 13,036  $ 11,598  $ 38,143  $ 37,320
Net loss attributable to noncontrolling interests 258 511
Interest expense, net 3,023 5,255 8,959 10,591
Provision for income taxes 7,562 7,063 23,070 23,835
Depreciation and amortization 7,179 6,179 21,145 16,784
EBITDA  $ 31,058  $ 30,095  $ 91,828  $ 88,530
Facility rent—cost of services 3,374 3,331 10,063 10,380
EBITDAR  $ 34,432  $ 33,426  $ 101,891  $ 98,910
     
THE ENSIGN GROUP, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
 (In thousands)
  September 30,
2012
December 31,
2011
Assets    
Current assets:    
Cash and cash equivalents  $ 32,028  $ 29,584
Accounts receivable — less allowance for doubtful accounts of $13,628 and $12,782 at September 30, 2012 and December 31, 2011, respectively 98,072 86,311
Investments — current 4,254
Prepaid income taxes 3,232 5,882
Prepaid expenses and other current assets 7,985 7,667
Deferred tax asset — current 10,178 11,195
Total current assets 155,749 140,639
Property and equipment, net 439,233 403,862
Insurance subsidiary deposits and investments 18,149 16,752
Escrow deposits 175
Deferred tax asset 4,787 3,514
Restricted and other assets 12,385 10,418
Intangible assets, net 4,867 2,321
Goodwill 22,180 17,177
Other indefinite-lived intangibles 10,598 1,481
Total assets  $ 667,948  $ 596,339
     
Liabilities and equity     
Current liabilities:    
Accounts payable  $ 23,211  $ 21,169
Accrued wages and related liabilities 34,868 41,958
Accrued self-insurance liabilities — current 15,897 12,369
Other accrued liabilities 22,615 18,577
Current maturities of long-term debt 7,133 6,314
Total current liabilities 103,724 100,387
Long-term debt — less current maturities 192,299 181,556
Accrued self-insurance liabilities — less current portion 34,928 31,904
Fair value of interest rate swap 3,116 2,143
Deferred rent and other long-term liabilities 3,306 2,864
Total liabilities 337,373 318,854
Temporary equity — redeemable noncontrolling interest 11,511
Total equity 319,064 277,485
Total liabilities and equity  $ 667,948  $ 596,339
     
THE ENSIGN GROUP, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
 (In thousands)
The following table presents selected data from our condensed consolidated statements of cash flows for the periods presented:
     
  Nine Months Ended
September 30, 
  2012 2011
Net cash provided by operating activities  $ 51,593  $ 53,245
Net cash used in investing activities (61,841)  (126,870)
Net cash provided by (used in) financing activities 12,692  27,187
Net increase (decrease) in cash and cash equivalents 2,444  (46,438)
Cash and cash equivalents beginning of period 29,584  72,088
Cash and cash equivalents end of period  $ 32,028  $ 25,650
           
THE ENSIGN GROUP, INC.
SELECT PERFORMANCE INDICATORS
           
The following tables summarize our selected performance indicators, along with other statistics, for each of the dates or periods indicated:
           
  Three Months Ended
September 30,
     
  2012 2011      
  (Dollars in thousands) Change % Change
Total Facility Results:          
Revenue  $ 207,150  $ 196,346  $ 10,804  5.5 %
Number of facilities at period end  107  99  8  8.1 %
Actual patient days  872,701  812,627  60,074  7.4 %
Occupancy percentage — Operational beds 78.7% 78.7%   %
Skilled mix by nursing days 25.2% 24.9%    0.3 %
Skilled mix by nursing revenue 49.3% 51.3%    (2.0) %
  Three Months Ended
September 30,
     
  2012 2011      
  (Dollars in thousands) Change % Change
Same Facility Results(1):          
Revenue  $ 139,664  $ 144,357  $ (4,693)  (3.3) %
Number of facilities at period end  62  62  —  %
Actual patient days  537,256  536,500  756  0.1 %
Occupancy percentage — Operational beds 82.2% 81.8%    0.4 %
Skilled mix by nursing days 28.7% 28.7%    —  %
Skilled mix by nursing revenue 53.3% 55.7%    (2.4) %
  Three Months Ended
September 30,
     
  2012 2011      
  (Dollars in thousands) Change % Change
Transitioning Facility Results(2):          
Revenue  $ 37,163  $ 35,147  $ 2,016  5.7 %
Number of facilities at period end  20  20  —   —  %
Actual patient days  168,062  159,750  8,312  5.2 %
Occupancy percentage — Operational beds 75.7% 71.9%    3.8 %
Skilled mix by nursing days 18.8% 16.8%    2.0 %
Skilled mix by nursing revenue 40.0% 38.6%    1.4 %
  Three Months Ended
September 30,
     
  2012 2011      
  (Dollars in thousands) Change % Change
Recently Acquired Facility Results(3):          
Revenue  $ 30,323  $ 16,842  $ 13,481 NM  
Number of facilities at period end  25  17  8 NM  
Actual patient days  167,383  116,377  51,006 NM  
Occupancy percentage — Operational beds 71.9% 75.2%   NM  
Skilled mix by nursing days 16.8% 11.0%   NM  
Skilled mix by nursing revenue 37.0% 29.1%   NM  
_______________________          
           
(1)  Same Facility results represent all facilities purchased prior to January 1, 2009.
(2)  Transitioning Facility results represents all facilities purchased from January 1, 2009 to December 31, 2010.
(3)  Recently Acquired Facility (or "Acquisitions") results represent all facilities purchased on or subsequent to January 1, 2011.
           
  Nine Months Ended
September 30,
     
  2012 2011      
  (Dollars in thousands) Change % Change
Total Facility Results:          
Revenue  $ 613,618  $ 565,615  $ 48,003  8.5 %
Number of facilities at period end  107  99  8  8.1 %
Actual patient days  2,580,026  2,291,107  288,919  12.6 %
Occupancy percentage — Operational beds 79.2% 79.5%    (0.3) %
Skilled mix by nursing days 25.8% 25.8%    —  %
Skilled mix by nursing revenue 50.1% 52.2%    (2.1) %
  Nine Months Ended
September 30,
     
  2012 2011      
  (Dollars in thousands) Change % Change
Same Facility Results(1):          
Revenue  $ 421,993  $ 430,621  $ (8,628)  (2.0) %
Number of facilities at period end  62  62  —  %
Actual patient days  1,614,554  1,601,360  13,194  0.8 %
Occupancy percentage — Operational beds 82.9% 82.3%    0.6 %
Skilled mix by nursing days 29.6% 29.2%    0.4 %
Skilled mix by nursing revenue 54.3% 56.2%    (1.9) %
  Nine Months Ended
September 30,
     
  2012 2011      
  (Dollars in thousands) Change % Change
Transitioning Facility Results(2):          
Revenue  $ 108,611  $ 104,442  $ 4,169  4.0 %
Number of facilities at period end  20  20  —   —  %
Actual patient days  493,258  481,277  11,981  2.5 %
Occupancy percentage — Operational beds 74.6% 73.0%    1.6 %
Skilled mix by nursing days 17.8% 16.2%    1.6 %
Skilled mix by nursing revenue 38.3% 37.7%    0.6 %
  Nine Months Ended
September 30,
     
  2012 2011      
  (Dollars in thousands) Change % Change
Recently Acquired Facility Results(3):          
Revenue  $ 83,014  $ 30,552  $ 52,462 NM  
Number of facilities at period end  25  17  8 NM  
Actual patient days  472,152  208,453  263,699 NM  
Occupancy percentage — Operational beds 72.9% 75.1%   NM  
Skilled mix by nursing days 17.4% 13.2%   NM  
Skilled mix by nursing revenue 38.6% 32.9%   NM  
_______________________          
           
(1)  Same Facility results represent all facilities purchased prior to January 1, 2009.
(2)  Transitioning Facility results represents all facilities purchased from January 1, 2009 to December 31, 2010.
(3)  Recently Acquired Facility (or "Acquisitions") results represent all facilities purchased on or subsequent to January 1, 2011.
                     
THE ENSIGN GROUP, INC.
SKILLED NURSING AVERAGE DAILY REVENUE RATES AND
PERCENT OF SKILLED NURSING REVENUE AND DAYS BY PAYOR
                     
The following table reflects the change in the skilled nursing average daily revenue rates by payor source, excluding services that are not covered by the daily rate:
                     
  Three Months Ended September 30,
  Same Facility Transitioning Acquisitions Total %
  2012 2011 2012 2011 2012 2011 2012 2011 Change
Skilled Nursing Average Daily Revenue Rates:                    
Medicare  $ 564.05  $ 643.35  $ 483.99  $ 536.50  $ 464.93  $ 472.68  $ 539.13  $ 616.78  (12.6)%
Managed care 380.35 369.63 399.24 415.53 398.82 490.71 383.29 375.05  2.2%
Other skilled 565.92 538.68 582.27 550.61 568.60 539.85  5.3%
Total skilled revenue 494.56 535.11 467.43 509.47 454.10 474.63 487.11 529.46  (8.0)%
Medicaid 171.03 168.44 161.56 160.86 150.51 137.38 166.74 164.60  1.3%
Private and other payors 195.48 188.75 166.36 177.01 167.14 152.27 180.75 177.24  2.0%
Total skilled nursing revenue  $ 266.15  $ 275.75  $ 219.68  $ 221.55  $ 206.73  $ 180.37  $ 249.38  $ 257.06  (3.0)%
                     
  Nine Months Ended September 30,
  Same Facility Transitioning Acquisitions Total %
  2012 2011 2012 2011 2012 2011 2012 2011 Change
Skilled Nursing Average Daily Revenue Rates:                    
Medicare  $ 561.39  $ 640.30  $ 484.52  $ 535.07  $ 471.11  $ 468.00  $ 539.61  $ 617.12  (12.6)%
Managed care 371.90 368.52 405.64 424.72 405.85 489.89 376.64 373.99  0.7%
Other skilled 571.69 530.87 579.57 520.02 572.78 530.02  8.1%
Total skilled revenue 491.37 530.69 469.82 508.88 460.53 470.05 485.99 526.38  (7.7)%
Medicaid 170.11 167.54 162.71 160.42 147.24 138.87 166.22 164.76  0.9%
Private and other payors 197.05 187.29 170.78 173.71 165.15 156.45 182.19 179.69  1.4%
Total skilled nursing revenue  $ 267.72  $ 275.62  $ 218.53  $ 218.57  $ 207.64  $ 189.26  $ 250.98  $ 259.85  (3.4)%
                 
The following tables set forth our percentage of skilled nursing patient revenue and days by payor source for the three and nine months ended September 30, 2012 and 2011:
                 
  Three Months Ended September 30,
  Same Facility Transitioning Acquisitions Total
  2012 2011 2012 2011 2012 2011 2012 2011
Percentage of Skilled Nursing Revenue:                
Medicare 33.6% 37.9% 26.9% 29.6% 31.7% 25.8% 32.3% 35.9%
Managed care  15.5  14.3  9.5  7.2  5.3  3.3  13.4  12.5
Other skilled  4.2  3.5  3.6  1.8  —   —   3.6  2.9
 Skilled mix  53.3  55.7  40.0  38.6  37.0  29.1  49.3  51.3
Private and other payors  7.0  7.0  10.7  10.7  24.8  32.6  9.5  9.2
 Quality mix  60.3  62.7  50.7  49.3  61.8  61.7  58.8  60.5
Medicaid  39.7  37.3  49.3  50.7  38.2  38.3  41.2  39.5
Total skilled nursing 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
                 
                 
  Three Months Ended September 30,
  Same Facility Transitioning Acquisitions Total
  2012 2011 2012 2011 2012 2011 2012 2011
Percentage of Skilled Nursing Days:                
Medicare 15.9% 16.3% 12.2% 12.2% 14.1% 9.8% 14.9% 14.9%
Managed care  10.9  10.7  5.2  3.9  2.7  1.2  8.7  8.6
Other skilled  1.9  1.7  1.4  0.7  —   —   1.6  1.4
 Skilled mix  28.7  28.7  18.8  16.8  16.8  11.0  25.2  24.9
Private and other payors  9.5  10.2  14.2  13.3  30.8  38.7  13.2  13.3
 Quality mix  38.2  38.9  33.0  30.1  47.6  49.7  38.4  38.2
Medicaid  61.8  61.1  67.0  69.9  52.4  50.3  61.6  61.8
Total skilled nursing 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
                 
The following tables set forth our percentage of skilled nursing patient revenue and days by payor source for the three and nine months ended September 30, 2012 and 2011:
                 
  Nine Months Ended September 30,
  Same Facility Transitioning Acquisitions Total
  2012 2011 2012 2011 2012 2011 2012 2011
Percentage of Skilled Nursing Revenue:                
Medicare 34.8% 38.1% 26.6% 29.1% 33.1% 29.7% 33.3% 36.3%
Managed care  15.3  14.8  8.7  7.3  5.5  3.2  13.2  13.1
Other skilled  4.2  3.3  3.0  1.3  —   —   3.6  2.8
 Skilled mix  54.3  56.2  38.3  37.7  38.6  32.9  50.1  52.2
Private and other payors  7.0  7.1  10.6  10.6  26.0  30.7  9.5  8.6
 Quality mix  61.3  63.3  48.9  48.3  64.6  63.6  59.6  60.8
Medicaid  38.7  36.7  51.1  51.7  35.4  36.4  40.4  39.2
Total skilled nursing 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
                 
                 
  Nine Months Ended September 30,
  Same Facility Transitioning Acquisitions Total
  2012 2011 2012 2011 2012 2011 2012 2011
Percentage of Skilled Nursing Days:                
Medicare 16.6% 16.4% 12.0% 11.9% 14.6% 12.0% 15.5% 15.3%
Managed care  11.0  11.1  4.7  3.8  2.8  1.2  8.8  9.1
Other skilled  2.0  1.7  1.1  0.5  —   —   1.5  1.4
 Skilled mix  29.6  29.2  17.8  16.2  17.4  13.2  25.8  25.8
Private and other payors  9.6  10.4  13.6  13.4  32.7  37.2  13.2  12.4
 Quality mix  39.2  39.6  31.4  29.6  50.1  50.4  39.0  38.2
Medicaid  60.8  60.4  68.6  70.4  49.9  49.6  61.0  61.8
Total skilled nursing 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
                 
THE ENSIGN GROUP, INC.
REVENUE BY PAYOR SOURCE
                 
The following table sets forth our total revenue by payor source and as a percentage of total revenue for the periods indicated:
                 
  Three Months Ended
September 30,
Nine Months Ended
September 30,
  2012 2011 2012 2011
  $ % $ % $ % $ %
Revenue: (Dollars in thousands)
Medicaid  $ 76,709 37.0%  $ 70,967 36.1%  $ 223,934 36.5%  $ 204,273 36.1%
Medicare 69,526 33.6% 71,293 36.3%  209,715 34.2% 207,897 36.8%
Medicaid—skilled 6,316 3.0% 5,024 2.6%  18,590 3.0% 13,730 2.4%
Total 152,551 73.6% 147,284 75.0%  452,239 73.7% 425,900 75.3%
Managed Care 26,316 12.7% 23,621 12.0%  77,738 12.7% 71,938 12.7%
Private and Other 28,283 13.7% 25,441 13.0%  83,641 13.6% 67,777 12.0%
Total revenue  $ 207,150 100.0%  $ 196,346 100.0%  $ 613,618 100.0%  $ 565,615 100.0%
                 
Discussion of Non-GAAP Financial Measures
EBITDA consists of net income, adjusted for net losses attributable to noncontrolling interest, before (a) interest expense, net, (b) provisions for income taxes, and (c) depreciation and amortization. EBITDAR consists of net income before (a) interest expense, net, (b) provisions for income taxes, (c) depreciation and amortization, and (d) facility rent-cost of services. The Company believes that the presentation of EBITDA and EBITDAR provides important supplemental information to management and investors to evaluate the Company's operating performance. The Company believes disclosure of adjusted non-GAAP net income and non-GAAP diluted earnings per share has economic substance because the excluded expenses are infrequent in nature and are variable in nature, or do not represent current cash expenditures. A material limitation associated with the use of these measures as compared to the GAAP measures of net income and diluted earnings per share is that they may not be comparable with the calculation of net income and diluted earnings per share for other companies in the Company's industry. These non-GAAP financial measures should not be relied upon to the exclusion of GAAP financial measures. For further information regarding why the Company believes that this non-GAAP measure provides useful information to investors, the specific manner in which management uses this measure, and some of the limitations associated with the use of this measure, please refer to the Company's Report on Form 10-Q filed today with the SEC. The Form 10-Q is available on the SEC's website at www.sec.gov or under the "Financial Information" link of the Investor Relations section on Ensign's website at http://www.ensigngroup.net.


            

Tags


Contact Data